Safety assessment study on excessive intake of test supplement

Safety assessment study on excessive intake of test supplement - Safety assessment study on excessive intake of test supplement

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030679

Enrollment

Registered

2018-01-04

Start date

2018-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Intake of test supplement, 5-fold quantity of recommended daily intake, for 4 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Healthy male and female from 20 to 65 years of age

Exclusion criteria

Exclusion criteria: 1.Subjects who have a history or present serious disease such hepatic disorder, cardiovascular disorder, respiratory disorder, endocrine disorder, metabolic disorder. 2.Subjects who have a disease requiring regular medication. 3.Subjects who are at risk of developing allergy in relation to the test supplement 4.Subjects who are participating in other clinical trials when start of the examination period 5.Subjects who intend to become pregnant or lactating 6.Subjects who donated 200 mL in the past month or more than 400 mL within 3 months (blood donation etc.) 7.Subjects who are judged as unsuitable for the study by the principal doctor

Design outcomes

Primary

Measure	Time frame
Safety assessment on ingestion of test supplement, 5-fold quantity of recommended daily intake, for consecutive 4 weeks.	—

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. Representative Director

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026